About Pregmune
Pregmune is a Healthcare company based in Newton (United States) founded in 2020 by Andrea Vidali. Pregmune has raised $152 thousand across 2 funding rounds. Its chief executive is Andrea Vidali. Pregmune offers products and services including IRMA. Its focus areas include HealthTech, Healthcare IT, Provider and Clinical Operations. Its legal entity is Pregimmune Corp. Its competitors include Alife Health, Fairtility, LEVY Health, Cercle and Kai Health and 5 more; 7 of its 10 listed competitors have raised funding.
Company details
Digital reproduction and fertility abnormalities detection tool for healthcare professionals. The company is focused on building software that has the ability to evaluate abnormalities in a female reproductive system such as cases of miscarriage, infertility, and IVF.
- Headquarters Newton, United States
- Founders Andrea Vidali
- SectorsHealthcare
- Website pregmune.com
- Social LinkedIn Facebook Instagram
- Legal Name Pregimmune Corp
- Total Equity Funding$152K (USD)
in 2 rounds
- Latest Funding Round$125K (USD), Debt – Conventional
Sep 2022
Products & Services of Pregmune
Pregmune offers a comprehensive portfolio of products and services, including IRMA.
AI-powered assessment to detect immunological causes of infertility and IVF failures.
Funding Insights of Pregmune
Pregmune has successfully raised a total of $152K across 2 strategic funding rounds. The most recent funding activity was a Debt – Conventional round of $125 thousand completed in September 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $152,000
- Total Rounds 2
- Last Round Debt – Conventional — $125,000
- First Round $152,000
(May 2021)
All 2 funding rounds of Pregmune with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep 2022 | $125,000 | Debt – Conventional | – | – | – |
| May 2021 | $152,000 | Seed | – | – | – |
People of Pregmune
3 people are tracked at Pregmune (3 in leadership).
| Name | Role | Group |
|---|---|---|
Andrea Vidali | Founder & CEO | Leadership |
Marco Massini | Director & Chief Financial Officer | Leadership |
Nadera Mansouri-Attia | Chief Organization Officer | Leadership |
Complete people profiles for Pregmune
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Pregmune
3 dated milestones of Pregmune across 2 years, from founding to its latest funding, stage changes and deals.
- Founded Pregmune is founded.
- Funding First funding round of $152K.
- Funding Latest funding round, Debt – Conventional, of $125K.
Competitors of Pregmune
Pregmune has 10 listed competitors in our database, 7 of them funded. They include Alife Health, Fairtility, LEVY Health, Cercle and Kai Health, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| alifehealth.com | 2020 | Cambridge, United States | $31.5M | 23 | AI-based fertility care tools are supplied to clinicians for analysis. | |
| fairtility.com | 2019 | Tel Aviv, Israel | $15M | – | AI and cloud-based diagnosis tools for fertility treatments are developed. | |
| levy.health | 2020 | Berlin, Germany | $7.26M | – | Precision fertility diagnostics are supported by clinical decision software. | |
| cercle.ai | 2020 | Frisco, United States | $10.2M | – | Cercle is focused on advancing women's healthcare through AI-driven insights. | |
| kaihealth.tech | 2021 | Seoul, South Korea | – | – | Personalized fertility treatment solutions are provided using AI technology. | |
| lifewhisperer.com | 2016 | San Francisco, United States | – | – | AI-based embryo monitoring for IVF procedures is provided. | |
| illumicell.ai | 2023 | Allston, United States | $2.02M | – | AI-powered fertility screening tools are provided for clinics. | |
| weareclaire.health | 2020 | San Francisco, United States | $100,000 | – | Integrative health management platform for fertility treatment is provided. | |
| episona.com | 2013 | Los Angeles, United States | $4M | – | Male infertility is diagnosed through epigenetic analysis of sperm samples. | |
| cellpro.com.cn | 2012 | Ningbo, China | – | – | Assisted reproductive technology products are developed for diagnosis and treatment. |
Detailed competitors of Pregmune
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Pregmune
The website of Pregmune (pregmune.com) receives about 3.8K visits a month.
- Monthly visits3.8K
▲ 19.9% vs previous month
Top companies in Clinical IT & Data Platforms
10 companies that operate in the same segment as Pregmune (Clinical IT & Data Platforms), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Provider of fitness memberships encompassing group classes, gyms, and at-home workouts | 2016 | Bengaluru, Karnataka, India | USD 716.99 M | – | 1,832 | |
Employee health benefits are facilitated via a cloud-based platform. | 2007 | Plymouth Meeting, Pennsylvania, United States | USD 228.3 M | – | – | |
Healthcare appointments are booked online via Zocdoc's platform. | 2007 | New York, New York, United States | USD 425.97 M | USD 4.66 M | 1,365 | |
Virtual physical therapy and digital pain care solutions are provided. | 2015 | San Francisco, California, United States | USD 854.44 M | – | 1,746 | |
Tech-enabled mental health solutions for employers are provided. | 2016 | New York, New York, United States | USD 473.73 M | – | 3,902 | |
App-based health insurance is offered to individuals and businesses. | 2016 | Paris, Ile de France, France | USD 863.12 M | – | 1,606 | |
Virtual care programs for managing chronic diseases are provided. | 2011 | San Francisco, California, United States | USD 450.12 M | USD 260.21 M | 992 | |
AI-driven EMR and practice management software is delivered for clinics. | 2010 | Boca Raton, Florida, United States | USD 329.17 M | – | 2,470 | |
Cloud-based administrative tools for healthcare providers are offered. | 1997 | Watertown, United States | USD 40 M | – | – | |
Membership-based primary care platform is offered for employees and consumers. | 2007 | San Francisco, California, United States | USD 402.56 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Pregmune
Complete news archive for Pregmune
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Pregmune
Pregmune was founded in 2020 and raised its 1st funding round 1 year after it was founded.
Pregmune is headquartered in Newton, United States. It is registered at Newton, Massachusetts, United States.
Andrea Vidali is the current CEO of Pregmune. They have also founded this company.
Pregmune is a funded company, having raised a total of $152K across 2 funding rounds to date. The company's 1st funding round was a Seed of $152K, raised on May 2021.
Digital reproduction and fertility abnormalities detection tool for healthcare professionals. The company is focused on building software that has the ability to evaluate abnormalities in a female reproductive system such as cases of miscarriage, infertility, and IVF.
Pregmune's top competitors include Alife Health, LEVY Health and Cercle.
Pregmune offers IRMA.
Pregmune operates through Pregimmune Corp.